Previous close | 349.79 |
Open | 349.71 |
Bid | 345.52 x 800 |
Ask | 351.01 x 800 |
Day's range | 344.38 - 349.72 |
52-week range | 244.22 - 395.20 |
Volume | |
Avg. volume | 298,773 |
Market cap | 17.137B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | 59.58 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.06 (0.02%) |
Ex-dividend date | 20 Jan 2023 |
1y target est | N/A |
SAN RAMON, Calif., June 01, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced financial results for its fiscal second quarter ended April 30, 2023. Revenue increased 6% year-over-year to $877.4 million. CooperVision (CVI) revenue up 6% to $589.3 million, and CooperSurgical (CSI) revenue up 4% to $288.1 million.GAAP diluted earnings per share (EPS) of $0.80, down $1.75 or 69% from last year's second quarter.Non-GAAP diluted EPS of $3.08, down $0.16 or 5% from last year's second
SAN RAMON, Calif., May 23, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the Jefferies Healthcare Conference on Thursday, June 8, 2023. Dan McBride, Executive Vice President & Chief Operating Officer, will represent the Company in a session scheduled to begin at 2:00 PM ET. The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at http://investor.coopercos.com. A replay of the event will be available on the sa
SAN RAMON, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today released its 2022 Environmental, Social, and Governance (ESG) Report. It highlights the company's progress on social and environmental issues most important to its businesses and stakeholders, including employees, shareholders, customers, and global communities. In 2022, CooperCompanies manufactured a record number of products while reducing greenhouse gas (GHG) emissions by more than 7%. A big contributor to t
SAN RAMON, Calif., April 27, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced it will report second quarter 2023 financial results on Thursday, June 1, 2023, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 7116518. A simultaneous audio webcast can be accessed on CooperCompanies’ investor relations websi
SAN RAMON, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced financial results for its fiscal first quarter ended January 31, 2023. Revenue increased 9% year-over-year to $858.5 million. CooperVision (CVI) revenue up 4% to $581.3 million, and CooperSurgical (CSI) revenue up 23% to $277.2 million.GAAP diluted earnings per share (EPS) of $1.70, down $0.21 or 11% from last year's first quarter.Non-GAAP diluted EPS of $2.90, down $0.34 or 10% from last year's fir
SAN RAMON, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in KeyBanc’s Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2022. Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer, will represent the Company in a virtual session scheduled to begin at 1:30 PM ET. The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at http://investor.coopercos.com. A replay of t
SAN RAMON, Calif., Feb. 15, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in Oppenheimer’s 33rd Annual Healthcare Conference on Tuesday, March 14, 2022. Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer, will represent the Company in a virtual session scheduled to begin at 2:40 PM ET. The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at http://investor.coopercos.com. A replay of th
SAN RAMON, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced it will report first quarter 2023 financial results on Thursday, March 2, 2023, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 1757767. A simultaneous audio webcast can be accessed on CooperCompanies’ investor relations websit
SAN RAMON, Calif., Dec. 19, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced that it will hold its next annual meeting of stockholders on Wednesday, March 15, 2023. Stockholders of record as of the close of business on January 19, 2023, will be eligible to vote on matters presented in the Company's proxy statement, including electing its slate of directors. About CooperCompanies CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE: C
SAN RAMON, Calif., Dec. 14, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced that consistent with the plan approved by its board of directors to pay annual dividends, the Company declared a semi-annual dividend of 3 cents per share, payable on February 10, 2023, to stockholders of record on January 23, 2023. About CooperCompaniesCooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE: COO). Cooper operates through two business units, Co
SAN RAMON, Calif., Dec. 08, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced financial results for its fiscal fourth quarter and full year ended October 31, 2022. Fourth quarter revenue increased 12% year-over-year to $848.1 million. Fiscal 2022 revenue increased 13% to $3,308.4 million.Fourth quarter GAAP diluted earnings per share (EPS) of $1.32, down 89 cents or 40% from last year's fourth quarter. Fiscal 2022 GAAP diluted EPS of $7.76, down 87% from fiscal 2021.Fourth qua
SAN RAMON, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced it will release fourth quarter and full year 2022 financial results on Thursday, December 8, 2022, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The live dial-in number for the call is 800-715-9871. The conference ID is 2291153. A simultaneous webcast of the call will be available through the “Inv
SAN RAMON, Calif., Oct. 03, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) announced today that its Board of Directors has appointed Cynthia Lucchese as an independent director, effective October 1, 2022. Lucchese has also been appointed to serve on the Audit Committee and Corporate Governance and Nominating Committee when she joins the Board. “We are pleased to welcome Cindy to Cooper’s Board of Directors,” said Al White, President and CEO of CooperCompanies. “She is a highly successful e
SAN RAMON, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced financial results for its fiscal third quarter ended July 31, 2022. Revenue increased 10% year-over-year to $843.4 million. CooperVision (CVI) revenue up 2% to $566.3 million, and CooperSurgical (CSI) revenue up 35% to $277.1 million.GAAP diluted earnings per share $1.98, down $10.39 from last year's third quarter.Non-GAAP diluted earnings per share $3.19, down $0.22 or 6% from last year's third quar
SAN RAMON, Calif., Aug. 18, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the Wells Fargo Healthcare Conference on Wednesday, September 7, 2022. Al White, President and CEO, will represent the Company in a session scheduled to begin at 1:20 PM ET. A live webcast of the Company’s session can be accessed from Cooper’s investor relations website at http://investor.coopercos.com. A replay will be available on the same web page following the event. About CooperCompaniesCoo
SAN RAMON, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) announced today that Nicholas Khadder has been appointed as its general counsel and corporate secretary. Khadder joins Cooper having previously served as general counsel of Standard BioTools Inc. (formerly Fluidigm Corporation) from June 2016 to July 2022. Prior to joining Fluidigm, from 2010 to June 2016, Khadder held various positions at Amyris, Inc., including general counsel and corporate secretary from 2013 to
SAN RAMON, Calif., July 27, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced it will release third quarter 2022 financial results on Wednesday, August 31, 2022, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. To participate in the call please follow this link to register and receive the dial-in information. A simultaneous webcast of the call will be available through the “In